Silence Therapeutics today issued and allotted 100,000 new ordinary shares of 5p each following the exercise of share options under its Employee Share Option Scheme. The new ordinary shares rank pari passu with the existing ordinary shares in the company. Application will be made to the London Stock Exchange for the new ordinary shares to be admitted to trading on AIM. Admission is anticipated on 28 August 2019.
Following admission of the new ordinary shares, the total number of ordinary shares of 5p each in issue will be 78,094,027.